Zemcelpro® (dorocubicel) receives NUB Status 1 in Germany

The NUB designation for Zemcelpro® (dorocubicel) enables hospitals to immediately apply for temporary, supplementary reimbursement for its use. MONTREAL, Feb. 16, 2026 /PRNewswire/ -- ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and metabolic fitness, and...

Read More